ERC Success
Four Imperial scientists win European grants to develop research concepts
Four Imperial scientists have won prestigious European Research Council (ERC) grants to develop their research concepts.
Four Imperial scientists win European grants to develop research concepts
Four Imperial scientists have won prestigious European Research Council (ERC) grants to develop their research concepts.
Mint, Amber and GOLD - spinouts colour the future of neural implants
University spinouts are collaborating to advance therapeutic neural implants.
Imperial’s AI startups showcase ideas in Singapore
Some of Imperial’s most promising AI startups showcased their ideas to investors and industry leaders in Singapore.
New tool could transform study of cells and help find new drug targets
A new tool from Imperial and Molecular Dimensions could help biologists rapidly uncover valuable insights into the proteins found in cell membranes.
Imperial startups visit Ghana to build international connections
Seven startups from Imperial working on innovative health and sustainability solutions have visited Ghana to build connections in the country.
Eight things we learned about humans and technology at Tech Foresight Day 2024
The ways different generations interact with technology was the hot topic at Imperial Tech Foresight's latest event.
Imperial and BASF spinout SOLVE to digitally transform chemical manufacturing
A new spinout will use AI and innovative experimental methods to improve the manufacturing of products such as drugs and fertilisers.
The Imperial Incubator turns eighteen
Last month, Imperial celebrated 18 years of incubating startups with a special showcase event in White City.
Royal Academy of Engineering prizes for Imperial academics
Two Imperial researchers and two Imperial alumni have been awarded top honours by the Royal Academy of Engineering in its 2024 prize awards.
Imperial and Crick cancer drug spinout raises £90m to begin clinical development
Myricx Bio is bringing new therapeutic possibilities to the highly promising area of antibody-drug conjugates for treating cancer.